Danielle Krause, MD, discusses the effects of GLP-1 receptor agonist therapy in endometrial cancer.
Danielle Krause, MD
Advertisement
Articles by Danielle Krause, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
3
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
4
NCCN Guidelines Recognize MammaPrint/BluePrint for Determining Anthracycline Benefit in Breast Cancer
5